RNS Number : 2789K Renalytix PLC 31 August 2021   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

RNS Number : 2775K Renalytix PLC 31 August 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered

RNS Number : 2097K Renalytix PLC 31 August 2021   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered

RNS Number : 1082K Renalytix PLC 31 August 2021     Renalytix plc (" Renalytix " or the " Company ")     Renalytix Appoints Daniel J. Levangie to its Board of Directors   Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation

RNS Number : 8163J Renalytix PLC 26 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX TM Testing at Primary Care Level   Peer reviewed publication in Journal of Medical Economics supports payer coverage for

RNS Number : 6311I Renalytix PLC 13 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 13 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000

RNS Number : 9108H Renalytix PLC 06 August 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 6 August 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O. James Sterling , the Company's Chief Financial Officer, of 12,000

RNS Number : 2696H Renalytix PLC 02 August 2021   Renalytix plc   (" Renalytix " or the " Company ")     Total voting rights   New York , 2 August 2021 - Renalytix (LSE: RENX) announces that t he Company's total issued share capital consists of 72,229,786   shares of 0.25 pence each, with each

RNS Number : 1332H Renalytix PLC 30 July 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 30 July 2021 - Renalytix (LSE: RENX) announces that it has been advised of the sale by O . James Sterling , the Company's Chief Financial Officer, of 12,000

RNS Number : 6767G Renalytix PLC 28 July 2021     Renalytix Appoints Ann Berman to its Board of Directors   Berman serves on the board of Lowes Corporation , is a member of the board of trustees of Beth Israel Deaconess , and is a former chief financial officer of Harvard University     NEW YORK